Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Immune Pathways and Microbiome Disruption as Drivers of Mutagenesis in Oesophagogastric Cancer

NCT06057220 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.

NCT NCT06057220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06057220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Immune Pathways and Microbiome Disruption as Drivers of Mutagenesis in Oesophagogastric Cancer
Lead sponsor
Royal Marsden NHS Foundation Trust
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2023
Completion date
September 30, 2026
Enrollment
310 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

oesophagogastric cancer